148 related articles for article (PubMed ID: 31040910)
1. Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer.
Nishiguchi Y; Fujiwara-Tani R; Sasaki T; Luo Y; Ohmori H; Kishi S; Mori S; Goto K; Yasui W; Sho M; Kuniyasu H
Oncotarget; 2019 Mar; 10(22):2189-2202. PubMed ID: 31040910
[TBL] [Abstract][Full Text] [Related]
2. Targeting claudin-4 enhances chemosensitivity in breast cancer.
Luo Y; Kishi S; Sasaki T; Ohmori H; Fujiwara-Tani R; Mori S; Goto K; Nishiguchi Y; Mori T; Kawahara I; Kondoh M; Kuniyasu H
Cancer Sci; 2020 May; 111(5):1840-1850. PubMed ID: 32086991
[TBL] [Abstract][Full Text] [Related]
3. Anti-claudin-4 extracellular domain antibody enhances the antitumoral effects of chemotherapeutic and antibody drugs in colorectal cancer.
Fujiwara-Tani R; Sasaki T; Luo Y; Goto K; Kawahara I; Nishiguchi Y; Kishi S; Mori S; Ohmori H; Kondoh M; Kuniyasu H
Oncotarget; 2018 Dec; 9(100):37367-37378. PubMed ID: 30647838
[TBL] [Abstract][Full Text] [Related]
4. Pro-chemotherapeutic effects of antibody against extracellular domain of claudin-4 in bladder cancer.
Kuwada M; Chihara Y; Luo Y; Li X; Nishiguchi Y; Fujiwara R; Sasaki T; Fujii K; Ohmori H; Fujimoto K; Kondoh M; Kuniyasu H
Cancer Lett; 2015 Dec; 369(1):212-21. PubMed ID: 26342407
[TBL] [Abstract][Full Text] [Related]
5. CLDN4 silencing promotes proliferation and reduces chemotherapy sensitivity of gastric cancer cells through activation of the PI3K/Akt signalling pathway.
Luo J; Wang H; Chen H; Gan G; Zheng Y
Exp Physiol; 2020 Jun; 105(6):979-988. PubMed ID: 31856376
[TBL] [Abstract][Full Text] [Related]
6. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
Shang X; Lin X; Manorek G; Howell SB
Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
[TBL] [Abstract][Full Text] [Related]
7. Targeting claudin-4 enhances chemosensitivity of pancreatic ductal carcinomas.
Sasaki T; Fujiwara-Tani R; Kishi S; Mori S; Luo Y; Ohmori H; Kawahara I; Goto K; Nishiguchi Y; Mori T; Sho M; Kondo M; Kuniyasu H
Cancer Med; 2019 Nov; 8(15):6700-6708. PubMed ID: 31498559
[TBL] [Abstract][Full Text] [Related]
8. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma.
Satake S; Semba S; Matsuda Y; Usami Y; Chiba H; Sawada N; Kasuga M; Yokozaki H
Pathol Int; 2008 Mar; 58(3):156-63. PubMed ID: 18251778
[TBL] [Abstract][Full Text] [Related]
9. Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.
Maeda T; Murata M; Chiba H; Takasawa A; Tanaka S; Kojima T; Masumori N; Tsukamoto T; Sawada N
Prostate; 2012 Mar; 72(4):351-60. PubMed ID: 21656836
[TBL] [Abstract][Full Text] [Related]
10. Hypomethylation of
Maesaka F; Kuwada M; Horii S; Kishi S; Fujiwara-Tani R; Mori S; Fujii K; Mori T; Ohmori H; Owari T; Miyake M; Nakai Y; Tanaka N; Bhawal UK; Luo Y; Kondoh M; Fujimoto K; Kuniyasu H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742959
[TBL] [Abstract][Full Text] [Related]
11. Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β.
Murakami-Nishimagi Y; Sugimoto K; Kobayashi M; Tachibana K; Kojima M; Okano M; Hashimoto Y; Saji S; Ohtake T; Chiba H
Breast Cancer Res; 2023 Apr; 25(1):41. PubMed ID: 37059993
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis.
Chen X; Zhao J; Li A; Gao P; Sun J; Song Y; Liu J; Chen P; Wang Z
Onco Targets Ther; 2016; 9():3205-12. PubMed ID: 27313466
[TBL] [Abstract][Full Text] [Related]
13. Functional Analysis of Gastric Tight Junction Proteins in
Stein L; Brunner N; Amasheh S
Membranes (Basel); 2022 Jul; 12(8):. PubMed ID: 35893449
[TBL] [Abstract][Full Text] [Related]
14. Hypertonic stress increases claudin-4 expression and tight junction integrity in association with MUPP1 in IMCD3 cells.
Lanaspa MA; Andres-Hernando A; Rivard CJ; Dai Y; Berl T
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15797-802. PubMed ID: 18840681
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of claudin-4 in cholangiocarcinoma tissues and its possible role in tumor metastasis.
Bunthot S; Obchoei S; Kraiklang R; Pirojkul C; Wongkham S; Wongkham C
Asian Pac J Cancer Prev; 2012; 13 Suppl():71-6. PubMed ID: 23480768
[TBL] [Abstract][Full Text] [Related]
16. A non-tight junction function of claudin-7-Interaction with integrin signaling in suppressing lung cancer cell proliferation and detachment.
Lu Z; Kim DH; Fan J; Lu Q; Verbanac K; Ding L; Renegar R; Chen YH
Mol Cancer; 2015 Jun; 14():120. PubMed ID: 26081244
[TBL] [Abstract][Full Text] [Related]
17. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.
Rangel LB; Agarwal R; D'Souza T; Pizer ES; Alò PL; Lancaster WD; Gregoire L; Schwartz DR; Cho KR; Morin PJ
Clin Cancer Res; 2003 Jul; 9(7):2567-75. PubMed ID: 12855632
[TBL] [Abstract][Full Text] [Related]
18. Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis.
Peng W; Chen L; Liu J
Toxicol Res (Camb); 2023 Jun; 12(3):392-399. PubMed ID: 37397926
[TBL] [Abstract][Full Text] [Related]
19. H. pylori-encoded CagA disrupts tight junctions and induces invasiveness of AGS gastric carcinoma cells via Cdx2-dependent targeting of Claudin-2.
Song X; Chen HX; Wang XY; Deng XY; Xi YX; He Q; Peng TL; Chen J; Chen W; Wong BC; Chen MH
Cell Immunol; 2013; 286(1-2):22-30. PubMed ID: 24287273
[TBL] [Abstract][Full Text] [Related]
20. Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy.
Bang C; Park MG; Cho IK; Lee DE; Kim GL; Jang EH; Shim MK; Yoon HY; Lee S; Kim JH
Biomater Res; 2023 May; 27(1):53. PubMed ID: 37237291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
